Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew ManganInstitute of Innate Immunity, University of Bonn, Bonn, GermanyEdward J. OlhavaIFM Therapeutics, Boston, MA, USAWilliam RoushIFM Therapeutics, Boston, MA, USAH. Martin SeidelIFM Therapeutics, Boston, MA, USAGary D. GlickIFM Therapeutics, Boston, MA, USAEicke LatzGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
2018en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba